Personalized treatment of women with early breast cancer: a risk-group specific cost-effectiveness analysis of adjuvant chemotherapy accounting for companion prognostic tests OncotypeDX and Adjuvant!Online
Crossref DOI link: https://doi.org/10.1186/s12885-017-3603-z
Published Online: 2017-10-16
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jahn, Beate
Rochau, Ursula
Kurzthaler, Christina
Hubalek, Michael
Miksad, Rebecca
Sroczynski, Gaby
Paulden, Mike
Bundo, Marvin
Stenehjem, David
Brixner, Diana
Krahn, Murray
Siebert, Uwe